Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |